Shionogi & Co., Ltd. (4507.T)
JPY 2178.5
(0.51%)
JPY 2178.5
(0.51%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 435.08 Billion JPY | 1.97% |
| 2022 | 426.68 Billion JPY | 27.32% |
| 2021 | 335.13 Billion JPY | 12.77% |
| 2020 | 297.17 Billion JPY | -10.86% |
| 2019 | 333.37 Billion JPY | -8.34% |
| 2018 | 363.72 Billion JPY | 5.53% |
| 2017 | 344.66 Billion JPY | 1.7% |
| 2016 | 338.89 Billion JPY | 9.33% |
| 2015 | 309.97 Billion JPY | 13.13% |
| 2014 | 273.99 Billion JPY | -5.43% |
| 2013 | 289.71 Billion JPY | 2.41% |
| 2012 | 282.9 Billion JPY | 5.85% |
| 2011 | 267.27 Billion JPY | -5.34% |
| 2010 | 282.35 Billion JPY | 1.38% |
| 2009 | 278.5 Billion JPY | 22.41% |
| 2008 | 227.51 Billion JPY | 6.18% |
| 2007 | 214.26 Billion JPY | 7.26% |
| 2006 | 199.75 Billion JPY | 1.72% |
| 2005 | 196.38 Billion JPY | -1.49% |
| 2004 | 199.36 Billion JPY | -0.56% |
| 2003 | 200.48 Billion JPY | -29.71% |
| 2002 | 285.23 Billion JPY | -32.12% |
| 2001 | 420.18 Billion JPY | 1.82% |
| 2000 | 412.66 Billion JPY | 3.09% |
| 1999 | 400.28 Billion JPY | 7.55% |
| 1998 | 372.16 Billion JPY | 6.72% |
| 1997 | 348.74 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 116.38 Billion JPY | 19.26% |
| 2024 Q1 | 97.58 Billion JPY | -0.69% |
| 2023 Q1 | 109.31 Billion JPY | 23.74% |
| 2023 Q3 | 106.27 Billion JPY | -12.33% |
| 2023 Q2 | 121.23 Billion JPY | 10.9% |
| 2023 FY | 435.08 Billion JPY | 1.97% |
| 2023 Q4 | 98.26 Billion JPY | -7.54% |
| 2022 Q2 | 78.93 Billion JPY | 9.88% |
| 2022 FY | 426.68 Billion JPY | 27.32% |
| 2022 Q4 | 88.33 Billion JPY | -52.9% |
| 2022 Q1 | 71.83 Billion JPY | -37.81% |
| 2022 Q3 | 187.56 Billion JPY | 137.61% |
| 2021 Q4 | 115.51 Billion JPY | 54.97% |
| 2021 Q3 | 74.54 Billion JPY | -2.07% |
| 2021 Q2 | 76.11 Billion JPY | 10.37% |
| 2021 FY | 335.13 Billion JPY | 12.77% |
| 2021 Q1 | 68.96 Billion JPY | -5.21% |
| 2020 FY | 297.17 Billion JPY | -10.86% |
| 2020 Q1 | 71.4 Billion JPY | -10.59% |
| 2020 Q2 | 77.05 Billion JPY | 7.91% |
| 2020 Q3 | 75.96 Billion JPY | -1.41% |
| 2020 Q4 | 72.75 Billion JPY | -4.22% |
| 2019 Q1 | 79.22 Billion JPY | -19.55% |
| 2019 Q2 | 82.85 Billion JPY | 4.58% |
| 2019 Q3 | 91.11 Billion JPY | 9.97% |
| 2019 FY | 333.37 Billion JPY | -8.34% |
| 2019 Q4 | 79.85 Billion JPY | -12.36% |
| 2018 Q2 | 79.67 Billion JPY | -9.99% |
| 2018 Q4 | 98.47 Billion JPY | 1.48% |
| 2018 FY | 363.72 Billion JPY | 5.53% |
| 2018 Q1 | 88.52 Billion JPY | 8.88% |
| 2018 Q3 | 97.03 Billion JPY | 21.79% |
| 2017 Q3 | 91.19 Billion JPY | -6.13% |
| 2017 Q2 | 97.14 Billion JPY | 29.49% |
| 2017 Q1 | 75.02 Billion JPY | -8.91% |
| 2017 FY | 344.66 Billion JPY | 1.7% |
| 2017 Q4 | 81.3 Billion JPY | -10.84% |
| 2016 FY | 338.89 Billion JPY | 9.33% |
| 2016 Q2 | 81.94 Billion JPY | 12.01% |
| 2016 Q1 | 73.15 Billion JPY | -12.96% |
| 2016 Q3 | 101.43 Billion JPY | 23.78% |
| 2016 Q4 | 82.35 Billion JPY | -18.81% |
| 2015 FY | 309.97 Billion JPY | 13.13% |
| 2015 Q3 | 87.64 Billion JPY | 17.78% |
| 2015 Q2 | 74.41 Billion JPY | 16.52% |
| 2015 Q1 | 63.86 Billion JPY | -13.37% |
| 2015 Q4 | 84.05 Billion JPY | -4.1% |
| 2014 Q3 | 70.42 Billion JPY | 4.95% |
| 2014 FY | 273.99 Billion JPY | -5.43% |
| 2014 Q2 | 67.1 Billion JPY | 6.96% |
| 2014 Q1 | 62.73 Billion JPY | -12.4% |
| 2014 Q4 | 73.72 Billion JPY | 4.68% |
| 2013 Q4 | 71.61 Billion JPY | -9.78% |
| 2013 FY | 289.71 Billion JPY | 2.41% |
| 2013 Q1 | 67.26 Billion JPY | -5.87% |
| 2013 Q2 | 71.45 Billion JPY | 6.22% |
| 2013 Q3 | 79.38 Billion JPY | 11.1% |
| 2012 Q4 | 71.46 Billion JPY | -3.59% |
| 2012 FY | 282.9 Billion JPY | 5.85% |
| 2012 Q2 | 69.49 Billion JPY | 2.47% |
| 2012 Q1 | 67.82 Billion JPY | -1.05% |
| 2012 Q3 | 74.12 Billion JPY | 6.65% |
| 2011 Q2 | 60.28 Billion JPY | -5.4% |
| 2011 Q4 | 68.54 Billion JPY | -8.29% |
| 2011 Q1 | 63.72 Billion JPY | -2.09% |
| 2011 Q3 | 74.73 Billion JPY | 23.98% |
| 2011 FY | 267.27 Billion JPY | -5.34% |
| 2010 Q2 | 68.13 Billion JPY | -9.43% |
| 2010 Q1 | 75.23 Billion JPY | 4.41% |
| 2010 Q4 | 65.07 Billion JPY | -11.95% |
| 2010 Q3 | 73.9 Billion JPY | 8.47% |
| 2010 FY | 282.35 Billion JPY | 1.38% |
| 2009 Q4 | 72.05 Billion JPY | -2.39% |
| 2009 Q2 | 68.61 Billion JPY | 7.16% |
| 2009 Q1 | 64.02 Billion JPY | 2.22% |
| 2009 FY | 278.5 Billion JPY | 22.41% |
| 2009 Q3 | 73.81 Billion JPY | 7.58% |
| 2008 Q3 | 59.81 Billion JPY | 12.15% |
| 2008 FY | 227.51 Billion JPY | 6.18% |
| 2008 Q4 | 62.63 Billion JPY | 4.71% |
| 2008 Q2 | 53.33 Billion JPY | 0.0% |
| 2007 FY | 214.26 Billion JPY | 7.26% |
| 2006 FY | 199.75 Billion JPY | 1.72% |
| 2005 FY | 196.38 Billion JPY | -1.49% |
| 2004 FY | 199.36 Billion JPY | -0.56% |
| 2003 FY | 200.48 Billion JPY | -29.71% |
| 2002 FY | 285.23 Billion JPY | -32.12% |
| 2001 FY | 420.18 Billion JPY | 1.82% |
| 2000 FY | 412.66 Billion JPY | 3.09% |
| 1999 FY | 400.28 Billion JPY | 7.55% |
| 1998 FY | 372.16 Billion JPY | 6.72% |
| 1997 FY | 348.74 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -600.084% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 89.796% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | -38.315% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -5522.345% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | -193.468% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -503.91% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 41.344% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -3407.021% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | -207.031% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -322.881% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -685.26% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -1314.99% |
| Tsumura & Co. | 150.84 Billion JPY | -188.429% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -475.664% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -696.297% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | -90.88% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -964.054% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -474.553% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | -263.987% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -8532.56% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -827.777% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -7683.609% |
| MedRx Co., Ltd | 26 Million JPY | -1673288.462% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -3858.976% |
| Solasia Pharma K.K. | 617 Million JPY | -70415.559% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -592.33% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | -146.0% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -711840.372% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 70.537% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -1865.655% |